ProCE Banner Activity

Interdisciplinary Hemophilia A Education: Conversation Between Hematologists on the Evolution of Long-term Patient Care

Slideset Download
Download this slideset from an interactive presentation on the evolution of long-term care for patients with hemophilia A and how to address barriers to adherence.

Released: April 07, 2022

Expiration: April 06, 2023

Share

Faculty

Glaivy Batsuli

Glaivy Batsuli, MD

Assistant Professor of Pediatrics
Anne T. and Robert M. Bass Endowed Faculty Scholar in Pediatric Cancer and Blood Diseases
Stanford University School of Medicine
Pediatric Hematology, Oncology, Stem Cell Transplantation & Regenerative Medicine
Palo Alto, California

Guy Young

Guy Young, MD

Director, Hemostasis and Thrombosis Center
Director, Clinical Coagulation Laboratory
Cancer and Blood Disorders Institute
Children’s Hospital Los Angeles
Professor of Pediatrics
Division of Hematology/Oncology
Department of Pediatrics
University of Southern California Keck School of Medicine
Los Angeles, California

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Genentech, a member of the Roche Group

Partners

NHF

ProCE Banner

Faculty Disclosure

Primary Author

Glaivy Batsuli, MD

Assistant Professor of Pediatrics
Anne T. and Robert M. Bass Endowed Faculty Scholar in Pediatric Cancer and Blood Diseases
Stanford University School of Medicine
Pediatric Hematology, Oncology, Stem Cell Transplantation & Regenerative Medicine
Palo Alto, California

Glaivy Batsuli, MD, has disclosed that she has received consultant/advisor/speaker fees from Bio Products Laboratories and Kedrion.

Guy Young, MD

Director, Hemostasis and Thrombosis Center
Director, Clinical Coagulation Laboratory
Cancer and Blood Disorders Institute
Children’s Hospital Los Angeles
Professor of Pediatrics
Division of Hematology/Oncology
Department of Pediatrics
University of Southern California Keck School of Medicine
Los Angeles, California

Guy Young, MD, has disclosed that he has received consulting fees from Apcintex, BioMarin, Genentech/Roche, Grifols, Novo Nordisk, Pfizer, Rani, Sanofi Genzyme, Spark, Takeda, and UniQure and funds for research support from Genentech/Roche, Grifols, and Takeda.